HCW Biologics
By leveraging their immunology expertise, HCW is developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell clearance.
- Founded
- 2018
- Headcount
- 26
- Open roles
- 0
- Last raised
- Post Ipo Equity · $4M
- 01Engineering interview process at HCW BiologicsLocked
- 02Tech stack & infrastructure choicesLocked
- 03Culture & day-to-day work styleLocked
- 04Why join now vs. 6 months from nowLocked
- 05Hiring focus & open headcount by teamLocked
- 06Comp philosophy and band contextLocked
7-day free trial · $25/mo · cancel anytime
